[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100604578":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":14,"responsibleParty":30,"collaborators":7,"id":34,"slug":7,"hasResults":35,"nctId":36,"briefTitle":37,"officialTitle":38,"acronym":39,"eligibilityCriteria":40,"healthyVolunteers":35,"sex":41,"minAge":42,"maxAge":7,"enrollmentInfo":43,"targetDuration":46,"studyType":47,"phases":7,"briefSummary":48,"conditions":49,"keywords":54,"overallStatus":17,"whyStopped":7,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":67},{"fullName":5,"class":6},"University Hospital Schleswig-Holstein","OTHER",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Laura K Sievers, MD","CONTACT","+49 431 500 23001","Laura.Rakow@uksh.de",[15],{"facility":16,"status":17,"city":18,"state":7,"zip":19,"country":20,"countryCode":21,"cosmosGeoPoint":22,"geoPoint":27,"contacts":28},"University Hospital Schleswig- Holstein","RECRUITING","Kiel","24105","Germany","DE",{"type":23,"coordinates":24},"Point",[25,26],10.13489,54.32133,{"lat":26,"lon":25},[29],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},{"type":31,"investigatorFullName":32,"investigatorTitle":33,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Laura Katharina Sievers","Principal Investigator","100604578",false,"NCT07151339","Pilot Project Renal and Cardiovascular Tertiary Prevention in Preeclampsia","Pilotprojekt Renale Und kardiovaskuläre Tertiärprävention Nach Präeklampsie","EagleEye3P","Inclusion Criteria:\n\n* older than 18 yrs\n* diagnosed preeclampsia, HELLP syndrome or kidney disease durig pregnancy\n\nExclusion Criteria:\n\n* unable for informed consent","FEMALE","18 Years",{"count":44,"type":45},100,"ESTIMATED","12 Months","OBSERVATIONAL","Tertiary prevention program for women with preeclampsia, HELLP syndrome, kidney disease and pregnancy or associated conditions, including founding of a biobank. (Observational study since no interference with regular path of treatment suggested in national and international guidelines)",[50,51,52,53],"Preeclampsia","HELLP Syndrome","Eclampsia","Kidney Disease",[55,56,57],"cardiovascular prevention","preeclampsia","pregnancy","2025-08-28",{"date":60,"type":61},"2025-09-03","ACTUAL",{"date":63,"type":61},"2024-11-01",{"date":65,"type":45},"2030-11",{"name":5,"class":6},1]